Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Wednesday, October 8, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions Inc. will report its financial results for the third quarter of 2025 on October 29, 2025. A conference call is scheduled for 5:00 PM Eastern Time, where company executives will discuss the results. Participants can access the call via webcast or telephone after registering in advance. A replay will be made available on Emergent's Investors page.
Price reaction · baseline $9.92 (2025-10-07 close) · hit after-hours · clean, no other EBS news in the window
day 0 close · peak
-0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is set to report its financial results, indicating active business performance.
  • The scheduled conference call suggests transparency and engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, October 29, 2025, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2025.
Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Executive Vice President, CFO

Frequently Asked Questions

When will Emergent BioSolutions host their conference call?

Emergent BioSolutions will host the conference call on October 29, 2025, at 5:00 PM ET.

How can I access the conference call?

You can access the call live via webcast on Emergent’s Investors page or by phone after registering.

Do I need to register to join the conference call by phone?

Yes, prior registration is needed for participating via telephone.

Where can I find the replay of the conference call?

The replay will be available on the Investors page of Emergent’s website.

ShareAdd on Google
Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions Q3 2025 financial results conference call
Last updated: Oct 8, 2025

Biotech snapshot

Cash runway
$141M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FLU-IGIVPhase 2
Influenza A H3N2 →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →